Orca Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.6M Buy
10,348
+49
+0.5% +$10.5K 1.56% 20
2026
Q1
$2.24M Sell
10,299
-17
-0.2% -$3.77K 1.59% 22
2025
Q4
$2.35M Buy
10,316
+68
+0.7% +$15.5K 1.68% 21
2025
Q3
$2.37M Buy
10,248
+23
+0.2% +$4.68K 1.8% 18
2025
Q2
$1.9M Sell
10,225
-254
-2% -$47.2K 1.6% 21
2025
Q1
$2.2M Buy
10,479
+32
+0.3% +$6.22K 1.96% 16
2024
Q4
$1.86M Buy
+10,447
New +$1.92M 1.67% 20

Other funds holding ABBV

Orca Wealth Management's ABBV Position: Q2 2026 in Review

Orca Wealth Management increased its AbbVie (ABBV) stake by 0.48% in Q2 2026, buying an estimated $10.5K and bringing the position to 10,348 shares worth $2.6M. The position accounts for 1.56% of the portfolio, ranked #20.

Orca Wealth Management first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Orca Wealth Management held 10,348 shares of AbbVie worth $2.6M as of Q2 2026.
  • Orca Wealth Management bought 49 AbbVie shares in Q2 2026, an estimated $10.5K.
  • AbbVie made up 1.56% of Orca Wealth Management's portfolio in Q2 2026, its #20 holding.
  • Orca Wealth Management first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Orca Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.